The Centers for Disease Control and Prevention (CDC), under the U.S. Department of Health and Human Services, is issuing a discretionary funding opportunity through Cooperative Agreement RFA-GH-18-000. This program falls under Assistance Listing 93.136, which supports Injury Prevention and Control Research as well as State and Community-Based Programs. With a focus on health-related initiatives, this opportunity aims to enhance public health infrastructure and foster partnerships to address injury prevention and control at the state and community levels.
The initiative is expected to distribute up to 100 awards through a cooperative agreement mechanism. Although the total program funding, award ceiling, and floor are not specified in the grant notice, the cooperative nature of the funding indicates close CDC involvement in project development and implementation. The funding opportunity emphasizes collaboration and coordination with CDC subject matter experts to ensure alignment with national public health priorities.
Eligibility for the grant extends to a broad range of organizations including state governments, universities, county governments, small businesses, and non-profit organizations. The program encourages a wide array of applicants capable of addressing the complex challenges of injury prevention. The eligibility section does not restrict geographic scope, implying nationwide reach.
Applicants are instructed to submit applications as necessary, with the application window open until September 30, 2030. The original posting date was October 13, 2023, and the current version of the notice was last updated on November 25, 2025. Although the application process lacks explicit pre-application requirements or detailed evaluation criteria in the available materials, applicants are encouraged to prepare standard components typically associated with CDC cooperative agreements, such as a detailed project narrative, budget justification, and organizational capability statements.
Questions or access issues related to the grant can be directed to Linton C. Browning, Grants Management Specialist, via phone at 770-488-2756 or email at lbrowning@cdc.gov. The grant opportunity does not specify a formal performance period or recurrence cadence, though the extended application window through 2030 suggests flexibility in project initiation and execution timelines.
